Open AccessSerum visfatin concentration and endothelial dysfunction in chronic kidney disease
Author(s) -
Mahmut İlker Yılmaz,
Mutlu Sağlam,
Juan Jesús Carrero,
Abdul Rashid Qureshi,
K. Çağlar,
T. Eyileten,
Alper Sönmez,
E. Çakır,
Müjdat Yenicesu,
Bengt Lindholm,
Peter Stenvinkel,
Jonas Axelsson
Publication year - 2007
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfm727
Subject(s) - medicine , kidney disease , endothelial dysfunction , endocrinology , kidney
Endothelial dysfunction (ED) is common in patients with moderate to advanced chronic kidney disease (CKD). Recently, visfatin, a protein with insulin-mimetic properties, was shown to be associated with sVCAM-1. Thus, we hypothesised that visfatin may be a marker of ED in CKD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom